Mitchell Eileen, Ahern Elayne, Saha Sanjib, Trepel Dominic
Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland and University of California, San Francisco, USA.
School of Biological Sciences, IGFS, Gibson Institute, Queen's University Belfast, Belfast, Northern Ireland, UK.
HRB Open Res. 2020 Dec 8;3:83. doi: 10.12688/hrbopenres.13144.2. eCollection 2020.
New emerging evidence has demonstrated the need for effective interventions to help people living with an acquired brain injury (ABI). Evidence on cost-effectiveness, which can help inform use of limited resources, is scarce in this area and therefore the purpose of this systematic review is to critically appraise and consolidate the current evidence on economic evaluations of ABI rehabilitation interventions. Systematic review methodology will be applied to identify, select and extract data from published economic evaluation studies (trial-based, non-trial based, simulation-based, decision model and trial-based model economic evaluations) of ABI treatment interventions in adults. A systematic literature search will be conducted on the following electronic databases: EMBASE, Econlit, CINAHL, Medline, the National Health Service Economic Evaluation Database and PsyclNFO. This review will only include cost-effectiveness analysis studies (e.g., cost per life year gained), cost-benefit and cost minimisation analyses in which the designs were randomised controlled trials (RCTs), non-RCT studies, cost-utility analyses (e.g., cost per quality-adjusted life year (QALY) gained or cost per disability-adjusted life year averted), cohort studies, and modelling studies. Only studies that were published in the english language, associated with adults who have an ABI will be included. There will be no restrictions on perspective, sample size, country, follow-up duration or setting. The search strategy terms will include the following: acquired brain injury, brain*; cost*; or cost-benefit analysis*. Following data extraction, a narrative summary and tables will be used to summarize the characteristics and results of included studies. The findings from this review will be beneficial to health policy decision makers when examining the evidence of economic evaluations in this field. In addition, it is anticipated that this review will identify gaps in the current economic literature to inform future-related research. PROSPERO CRD42020187469 (25 June 2020).
新出现的证据表明,需要采取有效的干预措施来帮助后天性脑损伤(ABI)患者。在这一领域,关于成本效益的证据稀缺,而成本效益证据有助于指导有限资源的使用,因此,本系统评价的目的是严格评估和整合当前关于ABI康复干预经济评估的证据。将应用系统评价方法,从已发表的成人ABI治疗干预经济评估研究(基于试验、非基于试验、基于模拟、决策模型和基于试验模型的经济评估)中识别、选择和提取数据。将对以下电子数据库进行系统的文献检索:EMBASE、Econlit、CINAHL、Medline、国家卫生服务经济评估数据库和PsyclNFO。本评价仅包括成本效益分析研究(如每获得一个生命年的成本)、成本效益分析和成本最小化分析,其中设计为随机对照试验(RCT)、非RCT研究、成本效用分析(如每获得一个质量调整生命年(QALY)的成本或每避免一个伤残调整生命年的成本)、队列研究和模型研究。仅纳入以英语发表的、与患有ABI的成人相关的研究。在视角、样本量、国家、随访时间或环境方面将不设限制。检索策略词将包括以下内容:后天性脑损伤、脑*;成本*;或成本效益分析*。在数据提取之后,将使用叙述性总结和表格来总结纳入研究的特征和结果。本评价的结果将有助于卫生政策决策者审查该领域经济评估的证据。此外,预计本评价将找出当前经济文献中的空白,为未来相关研究提供参考。PROSPERO CRD42020187469(2020年6月25日)